Basic Mercilon Information

• INN (International Nonproprietary Name): Desogestrel and Ethinyl Estradiol
• Brand Names Available In United Kingdom: Mircette (discontinued in USA, present in some international markets), Kariva, Azurette, Bekyree, Kimidess, Pimtrea, Viorele — packaging and availability vary by market and UK availability may be under Mercilon or generics from major manufacturers.
• ATC Code: G03AA11
• Forms & Dosages: Tablet containing 0.15 mg desogestrel + 0.02 mg ethinyl estradiol (commonly 21 active tablets) plus 2 inert and 5 ethinyl estradiol‑only (0.01 mg) tablets in some 28‑day packs.
• Manufacturers In United Kingdom: Not specified for a single UK manufacturer; generics and international suppliers include Teva, Amneal, Aurobindo, Zydus and Lupin.
• Registration Status In United Kingdom: Not specified in the provided data; multiple generics are registered across EU markets and availability may vary by national lists.
• OTC / Rx Classification: Prescription (Rx only) in all jurisdictions per the provided data.

Critical Warnings & Restrictions

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Patient safety comes first when considering a combined oral contraceptive such as mercilon.

This product contains desogestrel and ethinyl estradiol and is a prescription-only combined oral contraceptive that must not be used in pregnancy.

Absolute contraindications include pregnancy, prior deep vein thrombosis or pulmonary embolism, severe hepatic impairment or liver cancer, uncontrolled hypertension, migraine with aura, smoking if aged over 35, suspected or known hormone-dependent cancer, and undiagnosed abnormal genital bleeding.

Relative contraindications needing close monitoring include controlled hypertension, diabetes with vascular complications, hyperlipidaemia, certain migraine patterns, family history of thrombosis, obesity and recent immobilisation.

• Absolute Contraindications: Pregnancy; prior DVT/PE; severe hepatic disease; uncontrolled hypertension; migraine with aura; smoker aged >35; hormone-dependent cancer; undiagnosed vaginal bleeding; hypersensitivity.
• Relative Contraindications: Controlled hypertension; diabetes with vascular disease; hyperlipidaemia; family history of thrombosis; obesity; recent immobilisation.

Severe Hepatic Impairment

Marked liver dysfunction where oestrogen metabolism is significantly reduced and combined pills are contraindicated.

Post‑Menopause

Combined oral contraceptives are not indicated after the menopause.

Interaction With Activities (Driving, Workplace Safety Under UK Law)

Dizziness, syncope or severe nausea are rare adverse effects that can impair driving or the safe operation of machinery.

If symptoms occur, patients must stop driving or operating machinery immediately and seek review from a GP or pharmacist.

Under UK law, patients must not drive if their ability is impaired by medication side effects and should inform their insurer if an ongoing impairment exists.

Q&A — “Can I Drive After Taking It In The UK?”

Short answer: usually yes, unless you experience side effects such as dizziness, fainting or severe nausea.

• If you have dizziness, fainting, visual disturbance, severe nausea or syncope — do not drive.
• Report the event to your prescriber or pharmacist and ensure it is recorded in your clinical record.
• Report severe suspected adverse reactions to the MHRA Yellow Card scheme.

Usage Basics

INN, Brand Names Available In The UK

The active ingredients are desogestrel and ethinyl estradiol, the INN for mercilon‑type combined pills.

Packs commonly mirror the Mircette design with active and low‑dose ethinyl estradiol tablets, though UK supply may use the Mercilon brand or generics from Teva, Amneal, Aurobindo and others.

• Mercilon
• Mircette (design reference)
• Kariva (generic equivalent)
• Marvelon (related desogestrel/ethinyl estradiol formulation)

Legal Classification (POM, P, GSL)

Combined oral contraceptives such as mercilon are classified as Prescription Only Medicines (POM) in the provided data.

POM (Prescription Only Medicine)

Medicines that require a prescriber’s authorisation; combined pills fall into this category.

P (Pharmacy Medicine)

Available from a pharmacist without a prescription; not applicable for combined oral contraceptives per the provided data.

GSL (General Sale List)

Available widely without pharmacy oversight; not applicable here.

For NHS prescriptions, patients can obtain mercilon via a GP, sexual health clinic or a private prescriber and should check MHRA and NHS patient leaflets for product‑specific information.

Dosing Guide

Standard Regimens (NHS Guidelines)

Standard dosing is one tablet daily at the same time each day, using a 28‑day cycle with no pill‑free interval unless the pack instructs otherwise.

Packs commonly include 21 active tablets of 0.15 mg desogestrel + 0.02 mg ethinyl estradiol with additional low‑dose or inert tablets in some designs.

Follow the specific pack instructions for the product supplied, as some packs follow Mircette‑style biphasic layouts with low‑dose oestrogen days.

Adjustments For Comorbidities

Severe hepatic disease is a contraindication and alternatives should be considered where liver function is significantly impaired.

Complex cardiovascular risk such as obesity, diabetes with vascular disease or uncontrolled hypertension warrants alternative methods or specialist input.

Adolescents post‑menarche may use standard dosing; post‑menopausal use is not indicated.

• Pause and seek review with prolonged immobilisation, surgery, or new migraine aura.
• Discuss alternatives if starting enzyme‑inducing medicines or if severe renal or hepatic impairment exists.

Q&A — “What If I Miss A Dose?”

One missed active tablet: take it as soon as remembered and continue at the usual time; two tablets may be taken in one day.

More than one missed active tablet or missed pills during week 1 after unprotected sex: follow pack guidance, consider emergency contraception and use back‑up for 7 days.

Interaction Chart

Food And Drinks (Alcohol, Tea/Coffee, Diet Habits)

There are no clinically important food interactions specified for mercilon formulations.

Alcohol can worsen side effects such as nausea and dizziness and may affect judgement around taking doses on time.

Caffeine does not reduce contraceptive efficacy but may aggravate headaches in some users.

• Take tablets with or without food to improve tolerance and reduce nausea.
• Keep a spare strip in a bag for evenings out to avoid missed doses after alcohol.

Common Drug Conflicts (MHRA Yellow Card Data)

Enzyme‑inducing medicines can reduce plasma oestrogen and progestogen levels and reduce efficacy.

Suspected interactions or adverse reactions should be reported to the MHRA Yellow Card scheme.

User Reports & Trends

Patients commonly report initial breakthrough bleeding, mood changes, breast tenderness and headache during the early cycles of combined pills containing desogestrel and ethinyl estradiol.

Online forums and community sites show that some users switch products because of mood or persistent spotting, but forums carry selection bias and anecdote rather than systematic evidence.

• Common patient‑reported side effects: breakthrough bleeding, mood swings, nausea, breast tenderness, headaches.

There is an upward trend in online consultations and e‑prescriptions, with demand for home delivery rising while clinicians must ensure product licence and pharmacy accreditation such as GPhC registration.

Clinicians are advised to review patients within three months of initiation and document counselling and safety‑netting.

Access & Purchase Options

Boots, LloydsPharmacy, Superdrug

Patients can obtain mercilon via GP prescription, sexual health clinics or community pharmacies including national chains such as Boots, LloydsPharmacy and Superdrug where available.

• Bring a recent blood pressure reading if possible.
• Bring ID if requested by the pharmacy.
• Confirm pregnancy status before dispensing where relevant.

Online Pharmacies And NHS E‑Prescriptions

The NHS Electronic Prescription Service (EPS) supports GP‑issued e‑prescriptions that can be dispensed at a nominated pharmacy.

Accredited private online providers and GPhC‑registered pharmacies offer e‑consultation and home delivery; verify the product licence, batch details and expiry before accepting supply.

In our online pharmacy, mercilon is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Check regional prescription charging and entitlement before purchase, as exemptions apply to certain groups.

Mechanism & Pharmacology

Simplified Explanation

Combined desogestrel and ethinyl estradiol pills prevent pregnancy through several complementary mechanisms.

They suppress ovulation, increase cervical mucus viscosity to reduce sperm penetration and alter the endometrial lining to make implantation less likely.

Ovulation Suppression

Hormonal feedback prevents the mid‑cycle LH surge.

Cervical Mucus Viscosity

Thicker mucus reduces sperm movement and survival.

Endometrial Lining

The lining becomes less receptive to implantation.

Clinical Terms

The ATC code for desogestrel and ethinyl estradiol combinations is G03AA11.

Typical formulation contains 0.15 mg desogestrel and 0.02 mg ethinyl estradiol in the active tablets, with some pack designs including lower‑dose ethinyl estradiol tablets and inert tablets.

Oral administration leads to hepatic metabolism, and enzyme‑inducing drugs can lower systemic hormone levels and contraceptive efficacy.

• Teaching points: take daily at the same time, check for interacting medicines, report side effects early.

Indications & Off‑Label Uses

MHRA‑Approved Uses

The primary licensed indication is contraception, taken one tablet daily for ongoing prevention of pregnancy.

Prescribers should refer to the product SPC and MHRA information for product‑specific licence details and terms.

Off‑Label Practices In NHS And Private Care

Clinicians sometimes use combined pills for cycle control or to manage dysmenorrhoea or heavy menstrual bleeding where appropriate clinical judgement supports it.

Off‑label prescribing should be documented, discussed with the patient and based on best evidence.

Key Clinical Findings

Recent UK and EU evidence (2022–2025) continues to stratify VTE risk with combined oral contraceptives by progestogen type, age, BMI and smoking status.

Desogestrel/ethinyl estradiol formulations sit within the established combined‑pill safety profile, with relative VTE risk influenced by patient factors.

• Clinicians should monitor adherence and consider that 28‑day continuous packs may support continuation.

Recommended study topics to cite include VTE risk stratified by age, smoking and BMI; adherence and continuation rates; incidence of adverse effects; and comparative tolerability trials vs other formulations.

Monitor MHRA safety communications and Yellow Card signals for emerging evidence.

Alternatives Matrix

NHS Prescribing Alternatives (Comparison Table)

Pros And Cons Checklist

• Pros: predictable cycle control, ease of daily use, reversible fertility on stopping.
• Cons: adherence requirement, increased VTE risk in at‑risk populations, potential mood and bleeding changes.
• Clinician checklist: contraception goal, comorbidities, smoking, migraine history, BMI, interactions, desire for pregnancy soon.

Common Questions

Will Mercilon Affect My Weight?

Evidence shows minimal average weight change, though individual responses vary and lifestyle factors should be reviewed.

Can I Breastfeed On Mercilon?

Combined pills are generally avoided until breastfeeding is established; progestogen‑only methods are preferred during breastfeeding.

What If I Develop Migraine?

If a new migraine with aura occurs, stop the combined pill and seek review as combined pills are contraindicated with migraine with aura.

How Soon Is It Effective?

Start on Day‑1 of the period for immediate protection; other start methods require seven days of back‑up contraception.

• Escalate to GP or sexual health clinic if severe side effects occur.
• Contact emergency contraception services if multiple pills missed and unprotected sex occurred in week 1.

NHS Cost & Access Comparison Table

• Checklist for exemptions: age, pregnancy, low income, certain medical conditions — bring documentation to the pharmacy or clinic.

Registration & Regulation

MHRA Approval Process

The MHRA is responsible for approving and licensing medicines in the United Kingdom and clinicians should confirm MHRA licensing for the specific brand supplied.

SPC

Summary of Product Characteristics describing licensed use.

PIL

Patient Information Leaflet supplied with medicines.

Yellow Card Scheme

System for reporting suspected adverse reactions to the MHRA.

NHS Prescribing Framework

Local formularies, GP repeat prescribing and sexual health commissioning guide product selection in NHS practice.

• Clinician responsibilities: obtain informed consent, document baseline BP and BMI, review concomitant medicines, provide safety‑netting and record counselling.
• Verify licence, batch number and expiry when dispensing and report adverse events via Yellow Card.

Storage & Handling

UK Household Storage (Cold/Damp Climate)

Store below 25°C in original packaging and protect from moisture and light.

Avoid bathroom storage due to humidity and keep in a cool, dry place away from radiators.

• Keep out of reach of children.
• Do not split or crush tablets.
• Record batch and expiry if required for pharmacy or travel records.

Guidance From NHS And Pharmacists

Keep tablets in the original blister until use and carry prescription documentation when travelling.

Guidelines For Proper Use

UK Pharmacist Counselling Style

Use a structured checklist to ensure safe supply and consistent counselling for mercilon and equivalents.

• Confirm indication and informed consent.
• Review contraindications such as smoking status, migraine with aura and VTE history.
• Measure BP and BMI before supply.
• Review concomitant medications for enzyme inducers.
• Explain dosing, start options and the missed pill algorithm.
• Explain side‑effect recognition and driving/work safety.
• Advise when to seek urgent care.

NHS Patient Safety Advice

Recommend daily reminders such as phone alarms or pill apps and keeping a spare strip for travel.

Arrange a 3‑month review for tolerability and BP check, and report adverse events via the MHRA Yellow Card.

• Red Flags Requiring Urgent Review: unilateral leg pain or swelling, sudden chest pain, severe headache with visual change, jaundice, persistent severe abdominal pain.

Delivery Across United Kingdom